Available now: Open-access interviews with experts on the COVID-19 pandemic: epidemiology, virus biology and possible vaccines and treatmentsView All
Prof. Joshua Schiffman University of Utah, USA3 Talks
Schiffman earned his MD from Brown University, and completed his Pediatric Residency, Pediatric Chief Residency, and Pediatric Hematology/Oncology Fellowship at Stanford University, where he then served as an Instructor and directed the Pediatric Cancer Genetics Clinic (PCGC). In 2008, he joined the University of Utah as an Instructor, as well... read moreas an Investigator at Huntsman Cancer Institute. Within one year, he had risen to Assistant Professor in Pediatrics, and was promoted to Associate Professor in 2012.
Dr. Schiffman is dedicated to translating biological and genomic discoveries into clinical advances for patients. His research emphasis is cancer susceptibility in families, with a focus on the genomic changes underlying pediatric cancer development. He is pursuing copy number changes related to leukemia and sarcoma development, and functional assays related to risk of hereditary cancers. He is involved with the Utah Population Database (UPDB) to understand the risk factors associated with cancer development in children and their families. Dr. Schiffman runs a translational genomics research laboratory, where he combines both epidemiological and comparative oncology perspectives to advance the understanding of why children develop cancer. Dr. Schiffman is a member of several national and international research cooperative groups related to cancer risk and genetic epidemiology. He is also the Principal Investigator of the Cancer Genetics Study (CGS) which enrolls high risk families for genomic analysis. Dr. Schiffman has written more than 150 publications, scientific papers, chapters, and abstracts.